glp 1 new indications What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care The expanding benefits of GLP-1

primary-cta The Current Role of GLP-1s in Metabolic Health Independent licensed healthcare providers on the Eden platform may prescribe GLP-1 medications like semaglutide when clinically appropriate

Alongside the anticipated CV safety of many of these agents, evidence for certain sodiumglucose transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revealed potential cardioprotective effects in patients with T2D who are at high risk of CVD events

doi: 10.3390/ijms20215407

Several additional GLP-1 receptor agonists also display neuroprotective properties in preclinical AD models

Convenient program Quick online evaluation, personalized prescription, home delivery, and ongoing support throughout your journey

[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Andersen A, Knop FK, Vilsbll T